Trump Reverses Course to Fast-Track Psychedelic Drugs for Mental Healthcare
The president is pushing to accelerate research into psychedelics as mental health treatments, creating new investment opportunities alongside regulatory risks.
Read the full reporting at CNBC Markets.
Originally reported by CNBC Markets.